XXXX69HD一HD女,小荡货女友H调教,少妇撒尿W搡BBB搡WBBB搡,国产 一二三四五六

掃碼關(guān)注公眾號(hào)           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
成人免费毛片aaaaaa片,国产精品毛片无遮挡高清,欧美《熟妇的荡欲》未删减版
首頁 > 產(chǎn)品中心 > 常用試劑 > 產(chǎn)品信息
BCA Protein Assay Kit (C05-02001)  
訂購(gòu)熱線:400-901-9800
訂購(gòu)郵箱:sales@m.ahhuiguang.com
訂購(gòu)QQ:  400-901-9800
技術(shù)支持:techsupport@m.ahhuiguang.com
說明書: 下載
40ml(200T)/180.00元
100ml(500T)/318.00元
100ml×10(5000T)/2400.00元
大包裝/詢價(jià)

產(chǎn)品編號(hào) C05-02001
英文名稱 BCA Protein Assay Kit
中文名稱 BCA蛋白定量試劑盒
別    名 BCA Kit; bicinchoninic acid; BCA Assay Kit; Bicinchoninic Acid Kit for Protein Determination; BCA Protein Quantitative Kit;   BCA蛋白濃度測(cè)定試劑盒; BCA法蛋白質(zhì)含量測(cè)定; BCA蛋白質(zhì)定量試劑盒; BCA蛋白質(zhì)含量試劑盒; BCA蛋白質(zhì)含量檢測(cè)試劑盒; BCA蛋白定量試劑盒; BCA蛋白定量試劑盒; BCA試劑盒; 蛋白含量測(cè)定; BCA 蛋白定量分析試劑盒;
Specific References  (35)     |     C05-02001 has been referenced in 35 publications.
[IF=13.281] Qin Ouyang. et al. Brain-Penetration and Neuron-Targeting DNA Nanoflowers Co-Delivering miR-124 and Rutin for Synergistic Therapy of Alzheimer's Disease. 2022 Feb 19  Other ;  Other.  
[IF=10.107] Zhao Yin. et al. Discovery of Berberine that Targetedly Induces Autophagic Degradation of both BCR-ABL and BCR-ABL T315I through Recruiting LRSAM1 for Overcoming Imatinib Resistance. Clin Cancer Res. 2020 Aug;26(15):4040-4053  other ;  
[IF=9.417] Wen Zhang. et al. Construction of an ornidazole/bFGF-loaded electrospun composite membrane with a core-shell structure for guided tissue regeneration. MATER DESIGN. 2022 Sep;221:110960  
[IF=8.911] Yin Z et al. Discovery of berberine that targetedly induce autophagic degradation of both BCR-ABL and BCR-ABL T315I through recruiting LRSAM1 for overcoming imatinib-resistance. Clin Cancer Res. 2020 Feb 25.  Other ;  
[IF=7.666] Weiheng Zhang. et al. Long-Term Treatment with Gadopentetic Acid or Gadodiamide Increases TRPC5 Expression and Decreases Adriamycin Nuclear Accumulation in Breast Cancer Cells. CELLS-BASEL. 2023 Jan;12(9):1304  
[IF=7.31] Zitong Ma. et al. Epimedii Folium and Ligustri Lucidi Fructus Promote Osteoblastogenesis and Inhibit Osteoclastogenesis against Osteoporosis via Acting on Osteoblast-Osteoclast Communication. OXID MED CELL LONGEV. 2023 Jan 31;2023:7212642  
[IF=7.035] Jialiang Wei. et al. Protective role of TLR9-induced macrophage/microglia phagocytosis after experimental intracerebral hemorrhage in mice. CNS NEUROSCI THER. 2022 Jul;:  
[IF=6.706] Zefu Chen. et al. Polygonatum sibiricum saponin Exerts Beneficial Hypoglycemic Effects in Type 2 Diabetes Mice by Improving Hepatic Insulin Resistance and Glycogen Synthesis-Related Proteins. NUTRIENTS. 2022 Jan;14(24):5222  
[IF=6.638] Wang Z et al. Light-activatable?dual?prodrug?polymer?nanoparticle?for?precise?synergistic?chemotherapy?guidedby?drug-mediated?computed?tomography?imaging. Acta Biomater.?2019 May 22.  Other ;  
[IF=6.208] Haibo Yao. et al. Whole-Transcriptome Sequencing of Antler Tissue Reveals That circRNA2829 Regulates Chondrocyte Proliferation and Differentiation via the miR-4286-R+1/FOXO4 Axis. INT J MOL SCI. 2023 Jan;24(8):7204  
[IF=5.738] Gao Xiaoqiang. et al. Regulation of Gamma-Aminobutyric Acid Transaminase Expression and Its Clinical Significance in Hepatocellular Carcinoma. FRONT ONCOL. 2022 Jun;0:2857  
[IF=5.56] Wang Haoxia. et al. Influences of flavonoids from Sedum aizoon L. on biofilm formation of Pseudomonas fragi. APPL MICROBIOL BIOT. 2023 Apr;:1-11  
[IF=5.455] Qin, Gaofeng. et al. Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro. Chin Med-Uk. 2021 Dec;16(1):1-19  WB ;  Mouse.  
[IF=5.195] Zhangbi Wu. et al. Ginsenoside-Rg1 mitigates cardiac arrest-induced cognitive damage by modulating neuroinflammation and hippocampal plasticity. EUR J PHARMACOL. 2023 Jan;938:175431  
[IF=4.962] Yingying Chen. et al. SUZ12 participates in the proliferation of PNH clones by regulating histone H3K27me3 levels. 2022 Jan 06  Other ;  Other.  
[IF=4.547] Li Jie. et al. S100A9 plays a key role in Clostridium perfringens beta2 toxin-induced inflammatory damage in porcine IPEC-J2 intestinal epithelial cells. BMC GENOMICS. 2023 Dec;24(1):1-14  
[IF=3.974] Wei H et al. Alveolar macrophage reaction to PM2. 5 of hazy day in vitro: Evaluation methods and mitochondrial screening to determine mechanisms of biological effect.Ecotoxicol Environ Saf. 2019 Jun 15;174:566-573.  Other ;  
[IF=3.69] Zitong Ma. et al. Comprehensive evaluation of the combined extracts of Epimedii Folium and Ligustri Lucidi Fructus for PMOP in ovariectomized rats based on MLP-ANN methods. J Ethnopharmacol. 2021 Mar;268:113563  WB ;  
[IF=3.654] Mengying Zhang. et al. Preparation of Black pepper (Piper nigrum L.) essential oil nanoparticles and its antitumor activity on triple negative breast cancer in vitro. J FOOD BIOCHEM. 2022 Sep;:e14406  Other ;  Other.  
[IF=3.575] Li Li. et al. Circ_LPAR3 promotes the progression of oral squamous cell carcinoma (OSCC). Biochem Bioph Res Co. 2021 Dec;:  WB ;  Human.  
[IF=3.53] Adil Hassan et al. Anti-atherosclerotic effects of Lactobacillus plantarum ATCC 14917 in ApoE ?/? mice through modulation of proinflammatory cytokines and oxidative stress. Appl Microbiol Biotechnol. 2020 Jul;104(14):6337-6350.  WB ;  Mouse.  
[IF=3.399] SiZhe Yu. et al. NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway:. Technol Cancer Res T. 2021;():  WB ;  Human.  
[IF=3.318] Songsong Kang. et al. Tandem mass tag-based proteomics analysis reveals the effects of Guri Gumu-13 pill on drug-induced liver injury. J CHROMATOGR B. 2022 Jun;:123353  
[IF=3.241] Tang X et al. Evaluation of CaD on bone structure and bone metabolic changes in senile osteoporosis rats based on MLP-ANN methods. Food Funct. 2019 Nov 25.  Other ;  
[IF=3.093] Guo Xiao. et al. Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Peripheral and Central Tumor Necrosis Factor Alpha in Rats with Depression-Chronic Somatic Pain Comorbidity. Neural Plast. 2020;2020:8885729  
[IF=3.061] Jie Li. et al. Decreased S100A9 expression alleviates Clostridium perfringens beta2 toxin-induced inflammatory injury in IPEC-J2 cells. PEERJ. 2023 Jan;11:e14722  
[IF=2.959] Peng W et al.Expression of osteoprotegerin and receptor activator for the nuclear factor-κB ligand in XACB/LV-bFGF/MSCs transplantation for repair of rabbit femoral head defect necrosis.(2018) J. Cell. Biochem. Oct 18  WB ;  
[IF=2.532] Jianchao Ren. et al. Ejaculatory Duct Obstruction Affects Seminal Vesicle Contractile Efficacy and Smooth Muscle Ultrastructure in a Rat Model. ANDROLOGIA. 2023;2023:5022466  
[IF=2.089] Zhongxue Ye. et al. DNMT3B attenuated the inhibition of TET3 on epithelial-mesenchymal transition in TGF-β1-induced ovarian cancer by methylating the TET3 promoter. REPROD BIOL. 2022 Dec;22:100701  Other ;  Other.  
[IF=2.031] Yujing Wang. et al. SIRT1 promotes proliferation, migration, and invasion of cervical cancer cell and is upregulated by human papillomavirus 16 E7 oncoprotein. Gynecol Obstet Inves. ;:  WB ;  Human.  
保存條件 Store at -20℃.
注意事項(xiàng) This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 簡(jiǎn)介
蛋白質(zhì)定量是蛋白質(zhì)研究的基礎(chǔ)工作之一。BCA (bicinchoninic acid)是理想的蛋白質(zhì)定量方法;是當(dāng)前比Lowry法更優(yōu)越的專用于檢測(cè)總蛋白質(zhì)含量的產(chǎn)品。該方法以快速靈敏、穩(wěn)定可靠,對(duì)不同種類蛋白質(zhì)檢測(cè)的變異系數(shù)非常小而倍受專業(yè)人士的青睞。BCA法測(cè)定蛋白濃度不受絕大部分樣品中的化學(xué)物質(zhì)的影響。在組織細(xì)胞裂解實(shí)驗(yàn)中,常用濃度的去垢劑SDS,Triton X-100,Tween不影響檢測(cè)結(jié)果,但受螯合劑(EDTA,EGTA)、還原劑(DTT,巰基乙醇)和脂類的影響。實(shí)驗(yàn)中,若發(fā)現(xiàn)樣品稀釋液或裂解液本身背景值較高,可試用Bradford蛋白濃度測(cè)定試劑盒。該產(chǎn)品不受此影響,因此與之配合使用,可免除您實(shí)驗(yàn)中的許多煩惱。
基本原理:堿性條件下,蛋白將Cu2+還原為Cu+, Cu+與BCA試劑形成紫顏色的絡(luò)合物,測(cè)定其在562nm處的吸收值,并與標(biāo)準(zhǔn)曲線對(duì)比,即可計(jì)算待測(cè)蛋白的濃度。
BCA試劑的蛋白質(zhì)測(cè)定范圍是10-2000ug/ml

使用說明:
1. 配制工作液: 根據(jù)標(biāo)準(zhǔn)品和樣品數(shù)量,按體積比A :B (50:1)配制適量BCA工作液,充分混勻。BCA工作液室溫24小時(shí)內(nèi)穩(wěn)定。
2. 稀釋標(biāo)準(zhǔn)品:取10微升標(biāo)準(zhǔn)品用PBS稀釋至100ul(標(biāo)準(zhǔn)品一般可用PBS稀釋),使終濃度為0.5mg/ml。將標(biāo)準(zhǔn)品按0, 1, 2, 4, 8, 12, 16, 20ul加到96孔板的蛋白標(biāo)準(zhǔn)品孔中,加PBS補(bǔ)足到20ul。
3. 加適當(dāng)體積樣品到96孔板的樣品孔中,補(bǔ)加PBS到20ul。
4. 各孔加入200ul BCA工作液,37℃放置30分鐘。
5. 冷卻到室溫,用酶標(biāo)儀562nm測(cè)定OD值,根據(jù)標(biāo)準(zhǔn)曲線計(jì)算出蛋白濃度。

注意事項(xiàng):
1. 在低溫條件或長(zhǎng)期保存出現(xiàn)沉淀時(shí),可攪拌或37℃溫育使溶解, 如發(fā)現(xiàn)細(xì)菌污染則應(yīng)丟棄。
2. 樣品中若含有EDTA、EGTA、DTT、硫酸銨、脂類會(huì)影響檢測(cè)結(jié)果,請(qǐng)?jiān)囉肂radford蛋白濃度測(cè)定試劑盒;高濃度的去垢劑也影響實(shí)驗(yàn)結(jié)果,可用TCA沉淀去除干擾物質(zhì)。
3.要得到更為精確的蛋白濃度結(jié)果,每個(gè)蛋白梯度和樣品均需做復(fù)孔, 每次均應(yīng)做標(biāo)準(zhǔn)曲線。
4.當(dāng)試劑A和B混合時(shí)可能會(huì)有渾濁,但混勻后就會(huì)消失,工作液在密閉情況下可保存1周。
5.需準(zhǔn)備37℃水浴或溫箱、酶標(biāo)儀或普通分光光度計(jì),測(cè)定波長(zhǎng)為540-595nm之間,562nm最佳。酶標(biāo)儀需與96孔酶標(biāo)板配套使用。使用分光光度計(jì)測(cè)定蛋白濃度時(shí),試劑盒測(cè)定的樣品數(shù)量會(huì)因此而減 少。使用溫箱孵育時(shí),應(yīng)注意防止因水粉蒸發(fā)影響檢測(cè)結(jié)果。


本產(chǎn)品自2018年4月1日起配方升級(jí),規(guī)格和包裝有所調(diào)整,請(qǐng)以官網(wǎng)信息為準(zhǔn)。
產(chǎn)品圖片
C05-02001
版權(quán)所有 2004-2026 www.m.ahhuiguang.com 北京博奧森生物技術(shù)有限公司
通過國(guó)際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號(hào): 00124Q34771R2M/1100
通過國(guó)際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號(hào): CQC24QY10047R0M/1100
京ICP備05066980號(hào)-1         京公網(wǎng)安備110107000727號(hào)